TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10742	Companies
230457	Keywords
158880	Articles
122429	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 04/13/2026 at 08:00, 3 months 4 days ago

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene completes patient randomization in Phase 2 of clinical trial for TG4050 in adjuvant treatment of head and neck cancer. Top-line results expected by Q1 2028

Clinical Trial Head And Neck Cancer Phase 2 Transgene TG4050
BRIEF

published on 04/02/2026 at 17:50, 3 months 15 days ago

Transgene and NEC Bio Forge Partnership for TG4050 Development

License Agreement Transgene Neoantigen Vaccine NEC Bio TG4050 Development
PRESS RELEASE

published on 04/02/2026 at 17:45, 3 months 15 days ago

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Transgene and NEC Bio sign license agreement to advance development of TG4050 in head and neck cancer, leveraging AI technology for neoantigen selection

AI Technology Head And Neck Cancer Transgene TG4050 NEC Bio
BRIEF

published on 03/26/2026 at 17:50, 3 months 22 days ago

Transgene to Present TG4050 Vaccine Data at World Vaccine Congress

World Vaccine Congress Cancer Immunotherapy Transgene TG4050 Neoantigen Vaccine
PRESS RELEASE

published on 03/26/2026 at 17:45, 3 months 22 days ago

Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed

World Vaccine Congress Vaccine Transgene TG4050 Individualized Neoantigen
BRIEF

published on 01/23/2026 at 08:05, 5 months 25 days ago

Transgene strengthens its scientific committee with two immunotherapy experts.

Immunotherapy Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 01/23/2026 at 08:05, 5 months 25 days ago

Transgene Enhances Scientific Advisory Board with New Appointments

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE

published on 01/23/2026 at 08:00, 5 months 25 days ago

Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 11/27/2025 at 00:20, 7 months 21 days ago

Transgene: Resumption of Trading on Euronext Paris

Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE

published on 11/27/2025 at 00:15, 7 months 21 days ago

Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
Transgene resumes trading of shares on Euronext Paris following capital increase results publication

Euronext Paris Shares Trading Capital Increase Transgene

Accesswire

Published on 07/17/2026 at 15:00, 9 hours 46 minutes ago

Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 10 hours 46 minutes ago

Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 11 hours 46 minutes ago

Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 23 hours 46 minutes ago

RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 1 day ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

View all ACCESSWIRE

EQS Group

Published on 07/17/2026 at 20:35, 4 hours 11 minutes ago

Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 5 hours 51 minutes ago

CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:45, 6 hours 1 minute ago

NNS acquires shares in OCI
Published on 07/17/2026 at 18:32, 6 hours 14 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/17/2026 at 17:49, 6 hours 57 minutes ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review

Les Echos

Published on 07/17/2026 at 18:31, 6 hours 15 minutes ago

Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 6 hours 46 minutes ago

Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 7 hours 1 minute ago

Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 1 day 6 hours ago

Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 17:45, 1 day 7 hours ago

H1 2026 revenue: €6.1m (+14%)

View all LES ECHOS COMFI WIRE